Insider Selling: Grail, Inc. (NASDAQ:GRAL) CEO Sells 7,625 Shares of Stock

Grail, Inc. (NASDAQ:GRAL) CEO Robert P. Ragusa sold 7,625 shares of the stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.21, for a total value of $237,976.25. Following the transaction, the chief executive officer now owns 828,662 shares of the company’s stock, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Grail Stock Performance

NASDAQ GRAL traded up $0.31 on Wednesday, reaching $30.85. The stock had a trading volume of 1,392,942 shares, compared to its average volume of 1,224,902. The firm has a fifty day moving average of $31.16 and a two-hundred day moving average of $21.08. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $63.99.

Grail (NASDAQ:GRAL) last released its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. On average, equities analysts forecast that Grail, Inc. will post -15.15 EPS for the current year.

Hedge Funds Weigh In On Grail

Several hedge funds and other institutional investors have recently modified their holdings of GRAL. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in Grail in the fourth quarter valued at about $244,000. Moloney Securities Asset Management LLC acquired a new stake in shares of Grail during the 4th quarter worth approximately $559,000. Wesbanco Bank Inc. bought a new stake in Grail in the fourth quarter valued at $523,000. Rhumbline Advisers bought a new stake in Grail in the 4th quarter valued at about $456,000. Finally, Slow Capital Inc. acquired a new position in shares of Grail during the fourth quarter worth approximately $2,379,000.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on GRAL. Wolfe Research started coverage on Grail in a research note on Friday, November 15th. They set a “peer perform” rating on the stock. Morgan Stanley started coverage on shares of Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price on the stock.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.